Navigation Links
Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
Date:10/5/2007

sociated with a

greater likelihood of treatment response.

-- Genotypic or phenotypic testing and/or treatment history should guide

the use of APTIVUS/r. The number of baseline primary protease

inhibitor mutations affects the virologic response to APTIVUS/r.

-- Use caution when prescribing APTIVUS/r to patients with elevated

transaminases, hepatitis B or C co-infection or patients with mild

hepatic impairment.

-- Liver function tests should be performed at initiation of therapy with

APTIVUS/r and monitored frequently throughout the duration of

treatment.

-- The drug-drug interaction potential of APTIVUS/r when co-administered

with other drugs must be considered prior to and during APTIVUS/r use.

-- Use caution when prescribing APTIVUS/r in patients who may be at risk

for increased bleeding or who are receiving medications known to

increase the risk of bleeding.

-- The risk-benefit of APTIVUS/r has not been established in pediatric

patients.

There are no study results demonstrating the effect of APTIVUS/r on clinical progression of HIV-1.

APTIVUS/r does not cure HIV or help prevent passing HIV to others.

About RESIST

The RESIST clinical trial program consists of two ongoing Phase 3 pivotal trials, RESIST-1 and RESIST-2. Comprising one of the largest study programs conducted in treatment-experienced HIV patients, RESIST-1 includes 620 patients in the U.S., Canada and Australia, and RESIST-2 includes 863 patients in Europe and Latin America. The trial design and baseline patient characteristics are similar across studies. Patients enrolled in the RESIST studies were failing their current PI-based regimen, had received at least two previous PI-based regimens, had received prior treatment from at least three classes of antiretroviral agents and had documented PI resistance.

At the time of full approval,
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
2. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
3. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  RESMED INC. (NYSE: ... quarter of fiscal year 2015 results on Thursday, January 22, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
(Date:12/17/2014)... Revenue and earnings above the previous ... development In the past 2013/14 fiscal year (ended ... to EUR 4.287 billion (last year: EUR 4.190 billion) despite ... EUR 360 million. "Overall, 2013/14 was a successful fiscal year ... President and CEO of Carl Zeiss AG. "Thanks to our ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2
... to Initiate Phase 2b in Second Quarter of 2008 ... - Conference Call Tomorrow at 8:00 a.m. Eastern Time ... Inc.,(Nasdaq: RDEA ) today announced positive preliminary results ... novel,investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in,patients with human ...
... to Develop Disease Treatments for Diabetic Kidney Disease and ... Retinopathy, Each Multi-Billion-Dollar Drug Markets, JENKINTOWN, Pa., March ... new class of compounds that inhibit the,production of RAGE, ... that a RAGE inhibitor would be an important,addition to ...
Cached Medicine Technology:Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor 2
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
(Date:12/17/2014)... 17, 2014 While countless companies tempt patients ... realize the potential dangers of their purchase. Not only is ... a qualified doctor, but patients who buy hCG online are ... there is actually no real hCG present. Illegal internet hCG ... are no safety standards and may contain unknown fillers that ...
(Date:12/17/2014)... December 17, 2014 HeartMath® Inc., ... on stress, heart rate variability (HRV), heart coherence ... its extensive HRV databases and algorithms to chipset ... will enable HeartMath’s partners to offer its HRV ... research, as well as its normative HRV databases ...
(Date:12/17/2014)... 2014 Now in its second year, ... of the best in senior living and home care ... to communities and agencies that have received outstanding online ... the nearly 100,000 providers currently listed on SeniorAdvisor.com, only ... SeniorAdvisor.com Best of 2015 Awards are located all over ...
(Date:12/17/2014)... News) -- Expectant parents should leave prenatal picture-taking to ... Use of ultrasound imaging and heartbeat monitors to ... the agency warns. "Although there is a ... imaging and heartbeat monitors, prudent use of these devices ... an FDA biomedical engineer, said in an agency news ...
Breaking Medicine News(10 mins):Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:FDA Warns Against Fetal 'Keepsake' Videos 2
... to new research reported in the journal ... Shirota may ease symptoms of anxiety in people ... with CFS received daily supplements of either Lactobacillus ... Compared to the placebo group, those receiving ...
... loved one suffers a stroke, you,ll probably be left ... side effects should you watch for? Does your ... of the stroke survivor?To help answer common questions, the ... tips to help family members cope with their new ...
... soaks, twice a week, prevent painful flare-ups, study finds ... baths offer a safe, simple and inexpensive way of ... The skin disease, which affects 17 percent of school-age ... to concentrate in school. , Eczema-related itching can ...
... may now register to attend TCT 2009 (Transcatheter ... Cardiovascular Research Foundation. TCT gathers leading medical researchers ... and discuss the latest developments in the field ... its 21st year, TCT brings state-of-the-art techniques and ...
... Hospital,s Bluhm Cardiovascular Institute is the first ... country to implant a new experimental left ventricular assist ... condition where the heart cannot pump enough blood to ... System) features the HVAD Pump, the smallest ...
... fan technology teams up with ultraviolet-C light energy for ... the introduction of the Healthy Fan, which improves the ... 99 percent of airborne germs. The Healthy Fan maximizes ... combination with a mounted air purifying medallion. It ...
Cached Medicine News:Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2Health News:American Stroke Association Provides Tips for Caregivers as Part of Stroke Month in May 2Health News:American Stroke Association Provides Tips for Caregivers as Part of Stroke Month in May 3Health News:Diluted Bleach Baths Ease Kids' Eczema 2Health News:Media registration now open for TCT 2009 2Health News:Smallest full support heart assist device on trial at Northwestern Memorial 2Health News:Haledyne Debuts Air Sanitizing Technology for Healthier Home 2Health News:Haledyne Debuts Air Sanitizing Technology for Healthier Home 3
... for Cardiology is the first digital solution ... modalities both within and outside cardiology. From ... the archival solutions, Agfas combined expertise in ... and their customers to work the way ...
Full Digital Ultrasound System...
... the latest technologies to help expand your ... These advancements increase system utility and provide ... visualization of even the smallest details. And ... information delivery and expedite a higher quality ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Medicine Products: